Importantly, analysis from the METABRIC dataset of patient overall survival in both ER+/PR+ breast cancer and TNBC revealed low expression of IGF-1R significantly correlates with worse overall survival compared to high expression of IGF-1R (Fig. 1c). The gene discussed is IGF1R; the disease is breast cancer.